Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray vs midazolam nasal drops for pre-catheterization sedation in children with congenital heart disease
ChiCTR2500097372Phase 4Not yet recruiting
- Sponsor
- Qingdao Women and Children’s Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in None and Cardiovascular Malformation (CVM) (2 arms), sponsored by Qingdao Women and Children’s Hospital. Primary endpoint: Ramsay sedation score over time. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR2500097372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097372.